232 related articles for article (PubMed ID: 29635643)
1. LTBI among migrants by Mediterranean Sea: assessing prevalence and its variations according with different thresholds and diagnostic tools. A 10-month on-field experience.
Bertoncello C; Ferro A; Ferraresso A; Mascarello M; Fonzo M; Minascurta V; Pistellato I; Cabbia C; Cocchio S; Baldovin T; Baldo V
J Travel Med; 2018 Jan; 25(1):. PubMed ID: 29635643
[TBL] [Abstract][Full Text] [Related]
2. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
Campbell JR; Krot J; Elwood K; Cook V; Marra F
Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
[TBL] [Abstract][Full Text] [Related]
3. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
4. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
[TBL] [Abstract][Full Text] [Related]
5. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of tuberculosis screening for migrant children in a low-incidence country.
Usemann J; Ledergerber M; Fink G; Ritz N
Int J Tuberc Lung Dis; 2019 May; 23(5):579-586. PubMed ID: 31097066
[TBL] [Abstract][Full Text] [Related]
7. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
[TBL] [Abstract][Full Text] [Related]
8. Screening migrants from tuberculosis high-endemic countries for latent tuberculosis in Oman: A cross sectional cohort analysis.
Alyaquobi F; AlMaqbali AA; Al-Jardani A; Ndunda N; Al Rawahi B; Alabri B; AlSadi AM; AlBaloshi JA; Al-Baloshi FS; Al-Essai NA; Al-Azri SA; Al-Zadjali SM; Al-Balushi LM; Petersen E; Al-Abri S
Travel Med Infect Dis; 2020; 37():101734. PubMed ID: 32437967
[TBL] [Abstract][Full Text] [Related]
9. Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands.
Erkens CG; Dinmohamed AG; Kamphorst M; Toumanian S; van Nispen-Dobrescu R; Alink M; Oudshoorn N; Mensen M; van den Hof S; Borgdorff M; Verver S
Int J Tuberc Lung Dis; 2014 Apr; 18(4):413-20. PubMed ID: 24670695
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
[TBL] [Abstract][Full Text] [Related]
11. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
Hsia EC; Schluger N; Cush JJ; Chaisson RE; Matteson EL; Xu S; Beutler A; Doyle MK; Hsu B; Rahman MU
Arthritis Rheum; 2012 Jul; 64(7):2068-77. PubMed ID: 22238071
[TBL] [Abstract][Full Text] [Related]
12. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay.
Torres Costa J; Sá R; Cardoso MJ; Silva R; Ferreira J; Ribeiro C; Miranda M; Plácido JL; Nienhaus A
Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911
[TBL] [Abstract][Full Text] [Related]
15. Latent tuberculosis infection and associated risk factors among undergraduate healthcare students in Italy: a cross-sectional study.
Durando P; Sotgiu G; Spigno F; Piccinini M; Mazzarello G; Viscoli C; Copello F; Poli A; Ansaldi F; Icardi G
BMC Infect Dis; 2013 Sep; 13():443. PubMed ID: 24059355
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay.
Adams JW; Howe CJ; Andrews AC; Allen SL; Vinnard C
AIDS Care; 2017 Dec; 29(12):1504-1509. PubMed ID: 28486818
[TBL] [Abstract][Full Text] [Related]
17. Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data.
Stockbridge EL; Loethen AD; Annan E; Miller TL
PLoS One; 2020; 15(12):e0243102. PubMed ID: 33270737
[TBL] [Abstract][Full Text] [Related]
18. Tuberculin skin test versus interferon-gamma release assay in refugee children: A retrospective cohort study.
Elliot C; Marais B; Williams P; Joshua P; Towle S; Hart G; Zwi K
J Paediatr Child Health; 2018 Aug; 54(8):834-839. PubMed ID: 29442397
[TBL] [Abstract][Full Text] [Related]
19. Role of QuantiFERON(®)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit.
Gonzślez-Moreno J; García-Gasalla M; Gállego-Lezaun C; Fernández-Baca V; Mir Viladrich I; Cifuentes-Luna C; Serrano Bujalance A; Salom Vallespir A; Payeras Cifre A
Infect Dis (Lond); 2015 Apr; 47(4):244-51. PubMed ID: 25692351
[TBL] [Abstract][Full Text] [Related]
20. Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment.
Yoopetch P; Chitpim N; Jittikoon J; Udomsinprasert W; Thavorncharoensap M; Youngkong S; Praditsitthikorn N; Mahasirimongkol S; Chaikledkaew U
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]